Volunteers for clinical trials are imperative to the scientific research conducted in a trial. Clinical trials assist the diagnosis, treatment, drug therapy and prevention of diseases by researchers and doctors of all diseases.
A diverse group of volunteers are necessary to satisfy the demands and protocol of many clinical trials. The University of Michigan is reporting a shortage of volunteers, particularly of certain races and ethnicities for cancer trials; any disease with a genetic component can benefit from diverse volunteers as possible therapies or drugs can react differently within different ethnicities or races.
The Michael J. Fox Foundation for Parkinson’s Research has taken a proactive approach to match volunteers with clinical trials throughout the United States and countries throughout the world. The Fox Trial Finder is a one stop web locator which offers an easy to use interface for all interested volunteers.
Fox Trial Finder
The Michael J. Fox Foundation for Parkinson’s Research offers a clinical trial locator. The Fox Trial Finder locates clinical trials for volunteers who have and do not have Parkinson’s. The locator is an easy to use web tool to assist a volunteer is finding clinical trials locally or nationally.
Browse Trials Option
However, the Browse Trials option allows website views to browse trials throughout the country. A quick search of the database brought up over 390 trials for Parkinson’s. Details are included for each trial including the focus of the study, age group, inclusion and exclusion criteria as well as contact information for the trial team.
Phases Of A Clinical Trial
The information contained in a clinical trial states the phase of the trial. There are four phases in a clinical trial denoted by roman numerals I through IV. The results of each phase determine if a drug or procedure will proceed to the next phase.
The clinical trial phase of a drug is long and arduous; however any drug which does enter the clinical testing phase is a victory due to testing process required. What is learned from the trials and the results will ultimately determine if the FDA approves a new drug or procedure.